Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Han Ng

Showing results (171-180 of 207) with videos related to

Pageof 21
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant CandidatesWen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
Frontiers in Medicine|October 24, 2022
Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortalityCheng Han Ng, Jieling Xiao, Nicholas W S Chew, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 IndividualsJingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiencyDaniel Q Huang, Kai En Chan, Caitlyn Tan, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarctionYipHan Chin, Jieyu Lim, Gwyneth Kong, et al.
Plos One|December 30, 2022
A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectivesWen Hui Lim, Kai En Chan, Cheng Han Ng, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Hepatology|October 31, 2024
Liver cancer in 2021: Global Burden of Disease studyEn Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 23, 2022
A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver DiseaseClarissa Elysia Fu, Cheng Han Ng, Jie Ning Yong, et al.
Pageof 21

Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant CandidatesWen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.
Frontiers in Medicine|October 24, 2022
Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortalityCheng Han Ng, Jieling Xiao, Nicholas W S Chew, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 1, 2022
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 IndividualsJingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiencyDaniel Q Huang, Kai En Chan, Caitlyn Tan, et al.
Diabetes, Obesity & Metabolism|December 22, 2022
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarctionYipHan Chin, Jieyu Lim, Gwyneth Kong, et al.
Plos One|December 30, 2022
A qualitative systematic review of anonymous/unspecified living kidney and liver donors' perspectivesWen Hui Lim, Kai En Chan, Cheng Han Ng, et al.
United European Gastroenterology Journal|July 3, 2025
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021)Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Hepatology|October 31, 2024
Liver cancer in 2021: Global Burden of Disease studyEn Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 23, 2022
A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver DiseaseClarissa Elysia Fu, Cheng Han Ng, Jie Ning Yong, et al.
Pageof 21